FDA.reportPublic FDA data

12 HR doxylamine succinate 20 MG / pyridoxine hydrochloride 20 MG Extended Release Oral Tablet

RxCUI
1999651
RxNorm name
12 HR doxylamine succinate 20 MG / pyridoxine hydrochloride 20 MG Extended Release Oral Tablet
Display name
12 HR doxylamine succinate 20 MG / pyridoxine hydrochloride 20 MG Extended Release Oral Tablet
Full name
12 HR doxylamine succinate 20 MG / pyridoxine hydrochloride 20 MG Extended Release Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BONJESTADOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDEDuchesnay USA, Inc.dba60bb4-54ff-4e06-b8d2-acbbd37176662025-02-25Warnings, Adverse reactionsExact identifier
rxcui: 1999651

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dba60bb4-54ff-4e06-b8d2-acbbd3717666doxylamine succinate 20 MG / pyridoxine HCl 12HR 20 MG Extended Release Oral Tablet [PSN] · 12 HR doxylamine succinate 20 MG / pyridoxine hydrochloride 20 MG Extended Release Oral Tablet [SCD] · 12 HR doxylamine succinate 20 MG / vit-B6 Hydrochloride 20 MG Extended Release Oral Tablet [SY] · 12 HR doxylamine succinate 20 MG / vitamin B6 Hydrochloride 20 MG Extended Release Oral Tablet [SY] · doxylamine succinate 20 MG / pyridoxine hydrochloride 12 HR 20 MG Extended Release Oral Tablet [SY]513These highlights do not include all the information needed to use BONJESTA safely and effectively. See full prescribing information for BONJESTA. BONJESTA (doxylamine succinate and pyridoxine hydrochloride), extended-release tablets, for oral use. Initial U.S. Approval: 197620250225